145 related articles for article (PubMed ID: 20587668)
1. Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization.
Palanichamy JK; Mehndiratta M; Bhagat M; Ramalingam P; Das B; Das P; Sinha S; Chattopadhyay P
Mol Cancer Ther; 2010 Jul; 9(7):2114-22. PubMed ID: 20587668
[TBL] [Abstract][Full Text] [Related]
2. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected].
Khan I; Zakaria MK; Kumar M; Mani P; Chattopadhyay P; Sarkar DP; Sinha S
J Transl Med; 2015 Aug; 13():254. PubMed ID: 26242403
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.
Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X
Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
[TBL] [Abstract][Full Text] [Related]
6. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
Liu WL; Green N; Seymour LW; Stevenson M
Cancer Gene Ther; 2009 Oct; 16(10):764-75. PubMed ID: 19363466
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells.
Hong D; Lu W; Ye F; Hu Y; Xie X
Br J Cancer; 2009 Nov; 101(10):1798-804. PubMed ID: 19826423
[TBL] [Abstract][Full Text] [Related]
9. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
10. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
[TBL] [Abstract][Full Text] [Related]
11. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
13. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.
Kim MS; Bak Y; Park YS; Lee DH; Kim JH; Kang JW; Song HH; Oh SR; Yoon DY
Cell Biol Toxicol; 2013 Aug; 29(4):259-72. PubMed ID: 23955116
[TBL] [Abstract][Full Text] [Related]
14. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers.
Chang JT; Kuo TF; Chen YJ; Chiu CC; Lu YC; Li HF; Shen CR; Cheng AJ
Cancer Gene Ther; 2010 Dec; 17(12):827-36. PubMed ID: 20885450
[TBL] [Abstract][Full Text] [Related]
15. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
[TBL] [Abstract][Full Text] [Related]
16. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.
Niu XY; Peng ZL; Duan WQ; Wang H; Wang P
Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755
[TBL] [Abstract][Full Text] [Related]
19. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
20. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]